Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs like Zepbound and Wegovy in exchange for tariff relief and wider Medicare access.
Lilly, Novo To Lower Obesity Drug Prices In Trump Deal
About the Author: ryounglao
Leave A Comment